ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Cortexyme, Inc. Investors With Losses to Inquire About Securities Class Action Investigation

<!DOCTYPE html> <html lang="en" xmlns:wb="//open.weibo.com/wb"> <head> <meta charset="utf-8"> <title>ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Cortexyme, Inc. Investors With Losses to Inquire About Securities Class Action Investigation – CRTX - Business Wire China</title> <meta name="viewport" content="width=device-width, initial-scale=1.0"> <meta name="description" content="NEW YORK--(BUSINESS WIRE)--WHY:&nbsp;Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims"> <meta name="keywrods" content=""> <meta name="author" content="Business Wire China"> <link href="/css/bootstrap.css" rel="stylesheet"> <link href="/css/main.css?ver=20220804" rel="stylesheet"> <link href="/css/bootstrap-responsive.css" rel="stylesheet"> <script type="text/javascript" src="/js/jquery.min.js"></script> <script type="text/javascript" src="/js/bootstrap.js"></script> <script type="text/javascript" src="/js/main.js"></script>  <script src="//tjs.sjs.sinajs.cn/open/api/js/wb.js" type="text/javascript" charset="utf-8"></script> </head> <body>  <div class="header"> <div class="wrap"> <div class="container"> <div class="full_980 relative">  <div class="top_panel visible-desktop"> <a href="/zh">简体中文</a> | <a href="/hk">繁體中文</a> | <a href="/en">English</a> <div class="globalsite"><select id="globalsite" class="languages"><option value="0">Business Wire Global sites</option> <option value="1">Business Wire Global</option><option value="3">UK/Ireland</option><option value="4">Deutschland</option><option value="5">France</option><option value="6">Italy</option><option value="7">Japan</option> </select> </div> </div> <div class="logo"><a href="/en"><img src="/images/bwlogo_webmain_china.png" alt="Business Wire China" width="360" height="80"/></a></div> <div class="clear"></div> <div class="navigation"> <ul class="sf-menu"> <li class="current"><a href="/en">Home</a> </li> <li><a href="/en/news/index.html">News</a> </li> <li><a href="/en/events/index.html">Events</a> </li> <li><a href="/en/medias/index.html">Media Services</a> </li> <li><a href="/en/about/index.html">About Us</a> <ul> <li><a href="/en/about/contact.html">Contact Us</a></li> </ul> </li> </ul> <div class="clear"></div>  <div class="search_form visible-desktop"> <form action="/en/news/search" method="get"> <input class="inp_search" name="s" type="text" value="Search..." title="Search..." /> <input type="submit" class="search_btn" value=" " /> </form> </div>  </div>  </div> </div> </div> </div>   <div class="page_wrapper"> <div class="wrap"> <div class="container"> <div id="content"> <script src="http://tjs.sjs.sinajs.cn/open/api/js/wb.js?appkey=3616646312" type="text/javascript" charset="utf-8"></script> <script type="text/javascript" src="/js/swfobject.js"></script> <div class="full_980 main_wrap"> <div class="row"> <div class="span9 main_block story"> <p><img src="/files/logos/R/ROSEN_LOGO.jpg" alt="ROSEN 2021"></p> <h2 class="storytitle">ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Cortexyme, Inc. Investors With Losses to Inquire About Securities Class Action Investigation – CRTX</h2> <div class="storytimelang"> <span class="time">2022-04-07 14:39</span> <span class="lang"> <ul> <li><a href="/zh/news/50153.html"><img src="/images/zh_cn.png" alt="zh_cn"></a></li> <li><a href="/hk/news/50153.html"><img src="/images/zh_hant.png" alt="zh_hant"></a></li> <li><a href="/en/news/50153.html"><img src="/images/en.png" alt="en"></a></li> </ul> </span> <div class="clear"></div> </div> <ul class="industry-list"> <li><a href="/en/industry/legal.html" class="btn">Legal</a></li> </ul> <div class="storycontent"> <p> NEW YORK--(<span itemid="https://www.businesswire.com" itemprop="provider publisher copyrightHolder" itemscope="itemscope" itemtype="https://schema.org/Organization"><span itemprop="name"><a href="https://www.businesswire.com/" itemprop="url" referrerpolicy="unsafe-url" rel="nofollow">BUSINESS WIRE</a></span></span>)--<strong>WHY: </strong>Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Cortexyme, Inc. (NASDAQ: CRTX) resulting from allegations that Cortexyme may have issued materially misleading business information to the investing public.</p> <div> <div itemprop="articleBody"> <p> <strong>SO WHAT:</strong> If you purchased Cortexyme securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.</p> <p> <strong>WHAT TO DO NEXT: </strong>To join the prospective class action, go to <a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Frosenlegal.com%2Fsubmit-form%2F%3Fcase_id%3D3168&esheet=52652649&newsitemid=20220405006003&lan=en-US&anchor=https%3A%2F%2Frosenlegal.com%2Fsubmit-form%2F%3Fcase_id%3D3168&index=1&md5=48fbc6f0c1faadbfedf9454bcdda4d85" referrerpolicy="unsafe-url" rel="nofollow" shape="rect" target="_blank">https://rosenlegal.com/submit-form/?case_id=3168</a> or call Phillip Kim, Esq. toll-free at 866-767-3653 or email <a href="mailto:pkim@rosenlegal.com" referrerpolicy="unsafe-url" rel="nofollow" shape="rect" target="_blank">pkim@rosenlegal.com</a> or <a href="mailto:cases@rosenlegal.com" referrerpolicy="unsafe-url" rel="nofollow" shape="rect" target="_blank">cases@rosenlegal.com</a> for information on the class action.</p> <p> <strong>WHAT IS THIS ABOUT:</strong> On October 26, 2021, after market hours, Cortexyme issued a press release “report[ing] top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of atuzaginstat (COR388), an investigational orally administered small-molecule that targets gingipain proteases from the bacterium Porphyromonas gingivalis (P. gingivalis).” The press release reported, in relevant part, that the study had failed to meet statistical significance in its co-primary endpoints of improving cognitive and functional abilities in patients with mild-to-moderate Alzheimer’s disease. On this news, Cortexyme’s stock price fell $44.17 per share, or 76%, to close at $13.51 per share on October 27, 2021, damaging investors.</p> <p> Then, on January 26, 2022, before market hours, Cortexyme disclosed receipt of a letter from the U.S. Food and Drug Administration (“FDA”) advising that the FDA had “plac[ed] a full clinical hold on atuzaginstat’s (COR388) Investigational New Drug application (IND 134303).” On this news, Cortexyme’s stock price fell $2.85 per share, or over 31%, to close at $6.21 per share on January 26, 2022, further damaging investors.</p> <p> On February 1, 2022, Cortexyme issued a press release announcing plans to reduce its workforce by 53% in response to the clinical hold. That same day, Cortexyme announced the resignations of Casey Lynch, the Company’s CEO and Chair of the Board, and Steve Dominy, the Company’s Chief Scientific Officer and a director. On this news, Cortexyme’s stock price fell $0.67 per share, or over 9.8%, to close at $6.16 per share on February 2, 2022, further damaging investors.</p> <p> <strong>WHY ROSEN LAW: </strong>We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.</p> <p> Follow us for updates on LinkedIn: <a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fthe-rosen-law-firm&esheet=52652649&newsitemid=20220405006003&lan=en-US&anchor=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fthe-rosen-law-firm&index=2&md5=fd2b09136f60a6dcfd2e23c9c10a1952" referrerpolicy="unsafe-url" rel="nofollow" shape="rect" target="_blank">https://www.linkedin.com/company/the-rosen-law-firm</a>, on Twitter: <a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Ftwitter.com%2Frosen_firm&esheet=52652649&newsitemid=20220405006003&lan=en-US&anchor=https%3A%2F%2Ftwitter.com%2Frosen_firm&index=3&md5=6b409aa9d3516d0b97ca2a1c6a9bc5c6" referrerpolicy="unsafe-url" rel="nofollow" shape="rect" target="_blank">https://twitter.com/rosen_firm</a> or on Facebook: <a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.facebook.com%2Frosenlawfirm%2F&esheet=52652649&newsitemid=20220405006003&lan=en-US&anchor=https%3A%2F%2Fwww.facebook.com%2Frosenlawfirm%2F&index=4&md5=45a00d53301791a8bba8bf184c6729d8" referrerpolicy="unsafe-url" rel="nofollow" shape="rect" target="_blank">https://www.facebook.com/rosenlawfirm/</a>.</p> <p> Attorney Advertising. Prior results do not guarantee a similar outcome.</p> </div> <div> <h2> Contacts</h2> <p> Laurence Rosen, Esq.<br /> Phillip Kim, Esq.<br /> The Rosen Law Firm, P.A.<br /> 275 Madison Avenue, 40th Floor<br /> New York, NY 10016<br /> Tel: (212) 686-1060<br /> Toll Free: (866) 767-3653<br /> Fax: (212) 202-3827<br /> <a href="mailto:lrosen@rosenlegal.com" referrerpolicy="unsafe-url" rel="nofollow" shape="rect" target="_blank">lrosen@rosenlegal.com</a><br /> <a href="mailto:pkim@rosenlegal.com" referrerpolicy="unsafe-url" rel="nofollow" shape="rect" target="_blank">pkim@rosenlegal.com</a><br /> <a href="mailto:cases@rosenlegal.com" referrerpolicy="unsafe-url" rel="nofollow" shape="rect" target="_blank">cases@rosenlegal.com</a><br /> <a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.rosenlegal.com&esheet=52652649&newsitemid=20220405006003&lan=en-US&anchor=www.rosenlegal.com&index=5&md5=6c1c883ff9da59ea325a2a551ca17c31" referrerpolicy="unsafe-url" rel="nofollow" shape="rect" target="_blank">www.rosenlegal.com</a></p> </div> </div> </div> <div class="subjects"> <ul class="subject-list"> <li><a href="/en/subject/lawsuit.html">Lawsuit News</a></li> </ul> </div> <div class="clear"></div> <div class="commentbox"> <wb:comments url="auto" border="y" width="auto" skin="blue" appkey="3616646312" ></wb:comments> </div> </div> <div class="span3 sidebar"> <div class="widget"> <h3>Business Wire Weibo</h3> <wb:follow-button uid="2676312451" type="red_2" width="136" height="24" ></wb:follow-button> </div> <div class="widget"> <h3>Industries</h3> <ul class="industry"> <li><a href="/en/industry/corporate-social-responsibility">Corporate Social Responsibility</a></li> <li><a href="/en/industry/manufacturing">Manufacturing</a></li> <li><a href="/en/industry/chemical">Chemical</a></li> <li><a href="/en/industry/health-pharmaceutical">Health and Pharmaceutical</a></li> <li><a href="/en/industry/property">Property</a></li> <li><a href="/en/industry/travel">Travel</a></li> <li><a href="/en/industry/automotive">Automotive</a></li> <li><a href="/en/industry/life-entertainment">Life and Entertainment</a></li> <li><a href="/en/industry/energy-environmental">Energy and Environmental</a></li> <li><a href="/en/industry/retail">Retail</a></li> <li><a href="/en/industry/transportation">Transportation</a></li> <li><a href="/en/industry/business-ecommerce">Business and E-commerce</a></li> <li><a href="/en/industry/communications-media">Communications and Media</a></li> <li><a href="/en/industry/metals-mining">Metals and Mining</a></li> <li><a href="/en/industry/finance">Finance</a></li> <li><a href="/en/industry/technology">Technology</a></li> <li><a href="/en/industry/sports">Sports</a></li> <li><a href="/en/industry/education">Education</a></li> <li><a href="/en/industry/art-culture">Art and Culture</a></li> <li><a href="/en/industry/legal">Legal</a></li> </ul> </div> <div class="widget"> <h3>Latest Releases</h3> <ul class="story"> <li><span class="time">2024-11-27 12:04</span><br/><a href="/en/news/58418.html">NTT DATA Announces Intent to Acquire Niveus Solutions to Accelerate Global Leadership in Google Cloud</a></li> <li><span class="time">2024-11-27 11:59</span><br/><a href="/en/news/58417.html">Traditional Culture × Cutting-Edge Technology: "CHRONOSENSE" at Akasaka Palace</a></li> <li><span class="time">2024-11-27 11:53</span><br/><a href="/en/news/58416.html">Uniphore Joins the World Economic Forum’s Innovator Community</a></li> <li><span class="time">2024-11-27 11:47</span><br/><a href="/en/news/58415.html">Abu Dhabi’s Technology Innovation Institute Inaugurates Open-Source AI Summit with Critical Discussions on the Future of AI</a></li> <li><span class="time">2024-11-27 11:40</span><br/><a href="/en/news/58414.html">Ras Al Khaimah Named the World’s Top City for Expatriates ‘To Get Started Abroad’</a></li> </ul> </div> </div> </div> </div> </div> </div> </div> </div>   <div id="footer" class="hidden-phone"> <div class="wrap"> <div class="container"> <div class="full_980 relative">  <a href="#" id="totop_btn" class="visible-desktop visible-tablet"></a>   <div class="footer_top"> <div class="col940"> <div class="row"> <div class="span6"> <h4>Shanghai Office</h4> <p class="foot_home">Rm 1502 Xincheng Mansion, No. 167 Jiangning Rd, Shanghai, China</p> <p class="foot_phone">+86 21 5239 8905</p> <p class="foot_email"><a href="mailto:sh@businesswirechina.com">sh@businesswirechina.com</a></p> </div> <div class="span6"> <h4>Business Wire Hong Kong</h4> <p class="foot_home">51/F Hopewell Centre, 183 Queen's Road East<br/>Wan Chai, Hong Kong</p> <p class="foot_phone">+852 3602 3091</p> <p class="foot_email"><a href="mailto:hk@businesswire.com">hk@businesswire.com</a></p> </div> </div> </div> </div>   <div class="footer_bottom"> <div class="fleft"> <div class="copyright">© 2008-2016 Interfax Business Wire Service, all rights reserved.</div> </div> <div class="clear"></div> </div>  </div> </div> </div> </div> <script type="text/javascript"> var _gaq = _gaq || []; _gaq.push(['_setAccount', 'UA-669196-13']); _gaq.push(['_trackPageview']); (function() { var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true; ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js'; var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s); })(); </script> <script language="javascript"> $(document).ready(function() { $("#globalsite").bind("change",function(){ var links = ['','http://www.businesswire.com','http://www.businesswire.ca/','http://www.businesswire.co.uk/','http://www.businesswire.de/','http://www.businesswire.fr/','http://www.businesswire.it/','http://www.businesswire.jp/']; var val = $(this).val(); var link = links[val]; if(link.length>0) { window.open(link); } }); }); </script> </body> </html>

CINXE.COM

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Cortexyme, Inc. Investors With Losses to Inquire About Securities Class Action Investigation – CRTX - Business Wire China